| Entry |
|
|---|
| Name |
Phendimetrazine tartrate (USP);
Bontril (TN);
Statobex (TN) |
|---|
| Product |
|
|---|
| Generic |
PHENDIMETRAZINE TARTRATE (A-S Medication Solutions), PHENDIMETRAZINE TARTRATE (A-S Medication Solutions), PHENDIMETRAZINE TARTRATE (A-S Medication Solutions), PHENDIMETRAZINE TARTRATE (A-S Medication Solutions), PHENDIMETRAZINE TARTRATE (Bryant Ranch Prepack), PHENDIMETRAZINE TARTRATE (Bryant Ranch Prepack), PHENDIMETRAZINE TARTRATE (Bryant Ranch Prepack), PHENDIMETRAZINE TARTRATE (Bryant Ranch Prepack), PHENDIMETRAZINE TARTRATE (Calvin Scott &), PHENDIMETRAZINE TARTRATE (Elite Laboratories), PHENDIMETRAZINE TARTRATE (KVK-TECH), PHENDIMETRAZINE TARTRATE (NuCare Pharmaceuticals), PHENDIMETRAZINE TARTRATE (NuCare Pharmaceuticals), PHENDIMETRAZINE TARTRATE (PD-Rx Pharmaceuticals), PHENDIMETRAZINE TARTRATE (Preferred Pharmaceuticals), PHENDIMETRAZINE TARTRATE (Proficient Rx LP), PHENDIMETRAZINE TARTRATE (Virtus Pharmaceuticals) |
|---|
| Formula |
C12H17NO. C4H6O6
|
|---|
| Exact mass |
341.1475
|
|---|
| Mol weight |
341.36
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
|
|---|
| Remark |
| Product (DG01537): | D02080<US> |
|
|---|
| Efficacy |
Appetite suppressant (systemic), Stimulant (central) |
|---|
| Comment |
Morpholine derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
USP drug classification [BR:br08302]
Anti-Obesity Agents
Phendimetrazine
D02080 Phendimetrazine tartrate (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
DG01537 Phendimetrazine
D02080 Phendimetrazine tartrate
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
DG01537 Phendimetrazine
D02080 Phendimetrazine tartrate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D02080 Phendimetrazine tartrate (USP) <US>
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
DG01537 Phendimetrazine
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
DG01537 Phendimetrazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 24
1 C1y C 13.6729 -15.7602
2 C8y C 12.3038 -16.4312
3 C1y C 14.7975 -16.4891
4 O2x O 13.6372 -14.3604
5 C8x C 12.3396 -17.8310
6 C8x C 11.1791 -15.7024
7 N1y N 16.0266 -15.8181
8 C1a C 14.7633 -17.8889
9 C1x C 14.8663 -13.6894
10 C8x C 11.1105 -18.5020
11 C8x C 9.9502 -16.3733
12 C1x C 16.0609 -14.4182
13 C1a C 17.2214 -16.5470
14 C8x C 9.9158 -17.7731
15 O6a O 20.2528 -16.4966
16 C6a C 21.4658 -15.7968
17 C1c C 22.6788 -16.4966
18 C1c C 23.8917 -15.7968
19 C6a C 25.1047 -16.4966
20 O6a O 21.4658 -14.3972
21 O6a O 26.3176 -15.7968
22 O6a O 25.1047 -17.8961
23 O1a O 22.6788 -17.8961
24 O1a O 23.8917 -14.3972
BOND 24
1 1 2 1 #Down
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1 #Up
8 4 9 1
9 5 10 1
10 6 11 2
11 7 12 1
12 7 13 1
13 10 14 2
14 9 12 1
15 11 14 1
16 15 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 16 20 2
21 19 21 1
22 19 22 2
23 17 23 1 #Up
24 18 24 1 #Up
|
|---|
